Clinical Evaluation of the Click Sexual Health Test for the Detection of Neisseria Gonorrhoeae (NG), Trichomonas Vaginalis (TV), and Chlamydia Trachomatis (CT) in Women

CompletedOBSERVATIONAL
Enrollment

309

Participants

Timeline

Start Date

September 16, 2019

Primary Completion Date

December 3, 2019

Study Completion Date

December 3, 2019

Conditions
Chlamydial InfectionGonococcal InfectionTrichomoniasis
Interventions
DIAGNOSTIC_TEST

Click Sexual Health Test

The Click Device is a single-use (disposable), fully integrated, rapid, compact, device containing a polymerase chain reaction (PCR)-based nucleic acid amplification test (NAAT) for accurate, qualitative detection and differentiation of deoxyribonucleic acid (DNA) for Neisseria gonorrhea (NG), Trichomonas vaginalis (TV), and Chlamydia trachomatis (CT) organisms.

Trial Locations (5)

33308

Therafirst Medical Center, Fort Lauderdale

55114

Planned Parenthood North Central States, Saint Paul

63108

Planned Parenthood of the St. Louis Region and Southwest Missouri, St Louis

77023

Planned Parenthood Gulf Coast, Houston

08648

Lawrence OB/GYN Clinical Research, LLC, Lawrenceville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Visby Medical

INDUSTRY